CureGene Unveils Groundbreaking Preclinical Data for CG-0416, a Novel Oral Non-GLP-1 Therapy, at Obesity Week 2025

CG-0416, a highly liver-targeted THR-β agonist, demonstrates high-quality weight loss by reducing fat mass while preserving muscle, both as a monotherapy and in combination with GLP-1 RAs. ATLANTA, Nov. 11, 2025 /PRNewswire/ — CureGene Pharmaceuticals (“CureGene”) today announced the…
Itching at the GLP-1 site of injection

Some people will get itching at the site of injection of the GLP-1 drugs. This is not common but is irritating. There are some things you can do to lessen the severity of the reaction.
Now You Can Wear Your Vitamins

Last Thursday, in lieu of my afternoon coffee, I placed a sticker on the inside of my wrist. It was transparent, about the size of a dime, and printed with a line drawing of a lightning bolt—which, I hoped, represented the power about to be zapped into my radial vein. The patch had, after all, […]
AHA: GLP-1 Receptor Agonists Not Linked to Pancreatitis in Adults With High Triglycerides

MONDAY, Nov. 10, 2025 — For adults with type 2 diabetes and/or overweight/obesity and high triglycerides, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are not associated with pancreatitis, according to a study presented at the American…
Jim Cramer Says “I Think Pfizer’s Very Smart to Buy Metsera”

Pfizer Inc. (NYSE:PFE) is one of the stocks Jim Cramer offered insights on. Cramer discussed the company’s acquisition of Metsera during the episode. He commented: “There’s room for more than one winner in this race for GLP-1 weight loss supremacy, but some of these winners are going to be bigger than others. This morning, the […]
The GLP-1 Receptor Agonist Revolution: Is it Time for Everyone to Get Onboard the Incretin Train?

Publication date: 18 November 2025 Source: JACC, Volume 86, Issue 20 Author(s): Stephen J. Nicholls, Adam J. Nelson
GLP-1 Friendly Breakfast Ideas for Steady Energy

If you’re taking a GLP-1, you’re probably familiar with two big shifts: you feel full sooner and digestion may slow. (1) This may make a typical breakfast hard to finish—or tempting to skip altogether. The tradeoff? Missing breakfast can mean missing out on protein, fluids, and key micronutrients that support energy and help you feel […]
Hims & Hers Scales Technology-Enabled, Vertically Integrated Care

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, operates an integrated, proprietary technology platform that manages the full journey from customer discovery to ongoing clinical management. The platform connects consumers to a distributed provider network, a proprietary electronic medical record, digital prescribing, and in-house mail-order pharmacies, enabling subscription-based care across categories […]
GLP-1 drugs found to reduce mortality from colon cancer by over half (15.5% vs 37.1%), with effects especially strong for patients with BMI over 35.

submitted by /u/Lisei1128 [link] [comments]
Ozempic Weight Loss Ads; New Dietary Guidelines; More Type 1.5 Diabetes Diagnoses

(MedPage Today) — Due to sponsored search results — a form of online advertising — the Ozempic formulation of semaglutide appears in Google searches for weight loss, despite not being FDA-approved for this indication. (NPR)
New analyses…